Dr. Deborah Schrag, MD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 35
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 22
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
MA license 77651 · NY license 212739
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Memorial Solid Tumor Group (234 clinicians)
- Memorial Medical Consultation Group (76 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 22
- Services billed
- 71
- Patients’ average age
- 74
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 7 payments worth $301 in total to this clinician.
| Taiho Oncology, Inc. | $180 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $122 |
| Speaking at a medical education program | $208 |
|---|---|
| Travel and Lodging | $92.48 |
| Food and Beverage | $0.59 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Taiho Oncology, Inc. Mar 29, 2025 | Speaking at a medical education program | $124 |
| AstraZeneca Pharmaceuticals LP Mar 29, 2025 | Speaking at a medical education program | $84.32 |
| Taiho Oncology, Inc. May 31, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $31.15 |
| Taiho Oncology, Inc. Apr 30, 2025 | Travel and Lodging travel to Orlando, FL | $23.90 |
| AstraZeneca Pharmaceuticals LP May 31, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $21.18 |
| AstraZeneca Pharmaceuticals LP Apr 30, 2025 | Travel and Lodging travel to Orlando, FL | $16.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.